Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |